Truist Financial Cuts Leidos (NYSE:LDOS) Price Target to $165.00

Leidos (NYSE:LDOS) had its price target decreased by equities research analysts at Truist Financial from $185.00 to $165.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the aerospace company’s stock. Truist Financial’s target price points to a potential upside of 26.43% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. Citigroup raised their price target on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Robert W. Baird raised their price target on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. UBS Group began coverage on shares of Leidos in a research report on Monday, December 2nd. They set a “neutral” rating and a $182.00 price target on the stock. TD Cowen lowered shares of Leidos from a “buy” rating to a “hold” rating and lowered their price target for the stock from $200.00 to $165.00 in a research report on Wednesday, January 8th. Finally, Cantor Fitzgerald initiated coverage on shares of Leidos in a research note on Friday, February 7th. They set an “overweight” rating and a $185.00 price objective on the stock. Five analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Leidos presently has a consensus rating of “Moderate Buy” and a consensus target price of $176.27.

Leidos Price Performance

Shares of LDOS opened at $130.50 on Wednesday. The firm has a market capitalization of $17.41 billion, a PE ratio of 14.86, a PEG ratio of 0.92 and a beta of 0.66. The company’s 50-day moving average is $148.21 and its 200-day moving average is $157.48. Leidos has a fifty-two week low of $119.31 and a fifty-two week high of $202.90. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15.

Leidos (NYSE:LDOS) last issued its quarterly earnings data on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.13. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Equities analysts forecast that Leidos will post 10.03 EPS for the current year.

Insider Activity

In other Leidos news, Director Noel B. Geer bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average cost of $161.13 per share, for a total transaction of $322,260.00. Following the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $322,260. This represents a ? increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.96% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Leidos

Several hedge funds have recently added to or reduced their stakes in LDOS. Rakuten Securities Inc. boosted its position in Leidos by 1,460.0% during the 3rd quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock worth $25,000 after buying an additional 146 shares during the period. Duncker Streett & Co. Inc. acquired a new stake in Leidos during the 4th quarter worth approximately $27,000. Ashton Thomas Securities LLC bought a new position in Leidos during the 3rd quarter worth approximately $29,000. Berbice Capital Management LLC bought a new position in Leidos during the 4th quarter worth approximately $29,000. Finally, Northwest Investment Counselors LLC bought a new position in Leidos during the 3rd quarter worth approximately $30,000. 76.12% of the stock is currently owned by institutional investors and hedge funds.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.